• The complex of therapeutic and preventive measures for women with non-alcoholic fatty liver disease in preparation for ART programs

The complex of therapeutic and preventive measures for women with non-alcoholic fatty liver disease in preparation for ART programs

HEALTH OF WOMAN. 2016.6(112):169–172; doi 10.15574/HW.2016.112.169 
 

The complex of therapeutic and preventive measures for women with non-alcoholic fatty liver disease in preparation for ART programs


Boychuk A. G.

Shupyk National Medical Academy of Postgraduate Education, Kiev


The objective: To evaluate the effectiveness of complex therapeutic and preventive measures for women with non-alcoholic fatty liver disease in preparation for ART programs.


Materials and methods. To evaluate the effectiveness of therapeutic and preventive measures on the basis of the prediction algorithm in women with infertility and non-alcoholic fatty liver disease (NAFLD) identified 60 women with a high risk of inefficiencies ART. The method of randomization, patients were divided into: basic group – 30 women with a recommended set of preparations for the holding of ART, the comparison group – 30 women with preparations for ART according to the Ministry of Health protocols.

 

Results. Application reference system in women with infertility and NAFLD, which includes forecasting inefficiency ART and additional therapeutic and preventive measures to include gepatoprotektors, acid ursodeoxycholicum drugs, L-arginine, щ-3 fatty acids and probiotics, helped to improve the overall condition of the woman, a liver condition, cardiovascular regulation reduce symptoms of dysbiosis, hormonal status and reproductive system, as a result, increase the effectiveness of ART programs to population-wide level (pregnancy occurred in 36.7% of women).


Conclusions. Prove safety and high efficiency of complex therapeutic and preventive measures for women with infertility and NAFLD can be recommended for implementation in practice of reproductive medicine clinics, which will increase the effectiveness of ART, to preserve a woman’s health.


Key words: infertility, assisted reproductive technologies, non-alcoholic fatty liver disease, treatment.


REFERENCES

1. Blachier M, Leleu H, Peck-Radosavljevic M, Valla DC, Roudot-Thoraval F. 2013. The burden of liver disease in Europe: a review of available epidemiological data. J.Hepatol. 58(3):593–608. http://dx.doi.org/10.1016/j.jhep.2012.12.005; PMid:23419824

2. Byrne CD, Targher G. 2015. NAFLD: a multisystem disease.J. Hepatol. 62(1):S47–64.

3. Miyake T, Kumagi T, Furukawa S, Tokumoto Y, Hirooka M, Abe M, Hiasa Y, Matsuura B, Onji M. 2013. Non-alcoholic fatty liver disease: Factors associated with its presence and onset. J.Gastroenterol Hepatol. 28(4):71-8. http://dx.doi.org/10.1111/jgh.12251; PMid:24251708

4. Ratziu V, Goodman Z, Sanyal A. 2015. Current efforts and trends in the treatment of NASH. J.Hepatol. 62(1):S65–75.

5. Prosolenko KO. 2012. Current approaches to the treatment of nonalcoholic fatty liver disease on the background of metabolic syndrome. Lіki Ukraini 3–4(1):30-4.

6. Loomba R, Cortez-Pinto H. 2015. Exercise and improvement of NAFLD: practical recommendations. J.Hepatol. 63(1):10–2. http://dx.doi.org/10.1016/j.jhep.2015.03.009; PMid:25863525